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Abstract: China recently surpassed the USA as the greatest global source 
of patent applications. However, without internationally comparable 
measures of patent quality it remains questionable whether China’s patent 
expansion constitutes the rise of a new technological superpower. Our 
novel quality index is based on citations from international search reports 
and provides internationally comparable, quality-adjusted figures for 
applications made under the Patent Cooperation Treaty (PCT). We show 
that China’s patent expansion has taken place to the detriment of patent 
quality. Weighting national PCT counts with our index reveals a widening 
gap between the technological capacities of China and the leading USA.  
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1. Introduction 
Patent applications are a leading indicator of emerging technological prowess and 
indicate a global shift from the West to the East in recent years. Stimulated by national policy, 
e.g. patent subsidies, in 2011 China surpassed the USA as the greatest global source of patent 
applications (OECD 2014). Since 2013, China has ranked third in terms of applications made 
under the Patent Cooperation Treaty (PCT), typically preceding the international 
commercialization of valuable inventions (WIPO 2014a, Grupp and Schmoch 1999). 
However, without comparable information on patent quality it remains questionable whether 
China’s rapid expansion in PCT applications constitutes the rise of a new technological 
superpower. Although there is a consensus in the literature that frequent citations by 
subsequent patents indicate higher quality (Jaffe and Rassenfosse 2016, Harhoff et al. 1999, 
Trajtenberg 1990) and provide the best approximation of patent quality (Gambardella et al. 
2008, Reitzig 2004), currently available quality measures do not provide unbiased country 
comparisons. 
In this paper we develop a quality measure based on citations from international search 
reports (ISRs), generated during the international phase of PCT applications. Under the PCT 
system, applicants can simultaneously seek protection in up to 148 countries (WIPO 2014a). 
Our main index, which only considers citations of foreign PCT applications, not only allows 
for cross-country comparisons of patent quality but is also unaffected by national policies. 
Covering the start of China’s patent expansion, we apply our indices to the population of PCT 
applications filed between 2001 and 2009. For external validation of our measure, we 
calculate the indices for patent portfolios of all domestic firms listed in mainland China and 
regress those indices on relevant firm characteristics, such as R&D. 
We find that China’s PCT expansion has taken place to the detriment of patent quality. 
According to our main index, China’s average patent quality only reaches 32.1% of non-
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Chinese applicant countries and declines from 44.9% to 30.4% between 2001 and 2009. In 
global comparison, the USA leads with an average value of 123.3%, followed by Korea 
(93.5%), Germany (71.9%), and Japan (59.6%). We measure national technological capacity 
by quality-adjusted patent counts, i.e. by multiplying PCT counts with our index, and confirm 
the leading position of the USA. Without quality adjustment, China’s national technological 
capacity takes the third position, thereby overtaking Germany and Korea. If quality 
adjustment is applied, China remains in the fifth position and a widening gap between China 
and the leading USA is revealed. Regression results confirm that foreign PCT applications 
more often cite patents from Chinese firms with more extensive R&D but question the 
reliability of citations from Chinese PCT applications as quality measure. 
The contributions of this paper are twofold. First, we develop a measure of patent 
quality that allows for cross-country comparisons. Our indices have a wide applicability. 
Beyond the application in this study, they may be used to measure the quality of national 
patents for any country included in the minimum documentation required for prior art search 
during the international phase. Second, we provide novel evidence on the quality of China’s 
patents and technological capacity. While the policy-driven expansion of Chinese patent 
applications has occurred at the cost of quality, its technological capacity has increased less 
than would be expected if one considers only the number of patents applied for. Our results 
reveal that the number of Chinese patent applications and citations thereof are questionable 
measures of innovation levels and quality, respectively, and emphasize that measures stop 
serving as reliable measures if they become the target of policy (Goodhart 1975, Lucas 1976).  
Prior literature has investigated the quality of Chinese patents on the basis of citation-
based measures. Kwon et al. (2014) analyze patents granted at the US Patent and Trademark 
Office (USPTO) and find that patents with Chinese inventors closed the citation gap to 
patents with US-American inventors between 2000 and 2009. However, the comparability of 
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patents from China and the US is limited because firms tend to select only their more valuable 
inventions for protection abroad. Therefore Chinese patents are a positively selected sample. 
Branstetter et al. (2015) take a different angle by investigating the role of inventors and patent 
owners. Of patents granted at the USPTO with involvement from either Chinese inventors or 
firms, the ones with non-Chinese co-inventors or multinational firms as patent owners receive 
more citations compared to the fully Chinese patents. 
The remainder of the paper is organized as follows. In section 2, we develop our 
measure of patent quality that allows for unbiased cross-country comparison. In section 3 we 
apply the indices to the data and show results for patent quality, national technological 
capacities, and the external validation of our indices. Finally, section 4 offers a brief 
discussion of policy implications.  
 
2. Measurement of patent quality 
A challenge in assessing patents or in measuring national technological capacity using 
patent applications is that patents vary in their commercial value and technological impact. 
Evidence suggests that most patents are almost worthless, whereas only a few represent 
technological breakthroughs of high value (Gambardella et al. 2008). If explicit value 
information is not available, measures based on citations provide the best approximation of 
patent quality (Gambardella et al. 2008, Reitzig 2004). Frequent citations by subsequent 
patents indicate higher quality, given that differences affecting citation propensity, e.g. 
technology, are controlled for (Jaffe and Rassenfosse 2016, Harhoff et al. 1999, Trajtenberg 
1990). In cross-country studies, however, the comparability of citation counts has several 
limitations. First, as applicants only select more valuable patents for protection abroad (due to 
higher filing and translation costs), a direct comparison of domestic and foreign applications 
is hardly informative (Harhoff et al. 2003). Second, heterogeneous examination practices lead 
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to significant variation in citation counts generated across national patent offices (Michel and 
Bettels 2001). Third, patent examiners are biased towards citing domestic patents from their 
home country (Michel and Bettels 2001, Bacchiocchi and Montobbio 2010).  
We ensure comparability by exclusively relying on citations generated by ISRs during 
the international phase of PCT applications. Under the PCT system, applicants can 
simultaneously seek protection in up to 148 countries, typically preceding the international 
commercialization of valuable inventions (Grupp and Schmoch 1999, WIPO 2014a). A search 
for prior art occurs in the international phase within 30 months after filing the application. 
National patent offices act as international search authorities (ISAs) where all examiners 
follow the same strict examination rules from the World Intellectual Property Organization 
(WIPO) when drafting an ISR (WIPO 2014b). More details on the PCT process can be found 
in the appendix. 
Our quality measure allows for technology-specific cross-country comparisons. The 
ISR indexγκ defines the quality level of PCT applications, where the home country of the first 
applicant c=γ and technology class k=κ. The index is calculated at the annual level but we 
omit time indices to simplify notation. 
ܫܴܵ	݅݊݀݁ݔఊ఑ ൌ
ଵ
ேംഉ ∑ ൫∑ ܫܴܵܿ݅ݐ݁ݏ௜௝
ூ௝ୀଵ ൯ ∗ ߱௜఑ூ௜ୀଵ|௜∈௖ୀఊ
ଵ
ேംഥഉ ∑ ൫∑ ܫܴܵܿ݅ݐ݁ݏ௟௝
ூ௝ୀଵ ൯ ∗ ߱௟఑ூ௟ୀଵ|௟∈௖ୀఊഥ
 
߱௜఑ is the proportion of patent i within technology class κ. ఊܰ఑ is the sum of ߱௜఑ over 
all patents of country γ, i.e. ఊܰ఑ ൌ ∑ ߱௜఑ூ௜ୀଵ|௜∈௖ୀఊ . The comparison group is denoted by ̅ߛ	and 
contains all patents that do not belong to country γ. The indicator function ܫܴܵܿ݅ݐ݁ݏ௜௝ equals 
one if application i is cited by application j within the defined time window and zero 
otherwise. j ranges from 1 to I, i.e. it covers the full population of PCT applications. 
The country-level index is obtained by averaging ISR indices across technology 
classes:  
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ఊܰ is the total number of patents of country γ. A value of the ISR index of larger (smaller) 
than 100% signifies quality above (below) the comparison group.  
From now on we drop the country subscript γ and instead use the subscript to indicate 
the following citation types: foreign citations F, domestic citations D, and self citations S. The 
indicator function ܫܴܵܿ݅ݐ݁ݏ௜௝ of our main indexF only considers non-self-citations received by 
foreign countries, i.e. from countries other than the applicant country. In addition to non-self-
citations from foreign countries considered in indexF, the alternative indexFD also accounts for 
non-self-citations of domestic origin, which measure the technological self-reliance of an 
economy. By also considering self-citations, indexFDS acknowledges the extent to which an 
applicant builds on own prior art (Hall et al. 2005). Note that only our main indexF is invariant 
with respect to national policy as it relies only on citations generated outside of national 
boundaries.  
 
3. Empirical analysis 
3.1 Data 
Covering the start of China’s patent expansion in 2001, we consider the population of 
PCT applications with priority years between 2001 and 2009. The priority year indicates the 
year in which the first patent application for a specific invention was filed, irrespective of the 
chosen patent offices. Country allocations of applications are based on the address of the first 
applicant and only citations from distinct pairs of citing and cited patent families are 
considered. Self-citations are identified on the basis of DOCDB standard names from 
PATSTAT and EEE-PPAT applicant name harmonization (Magerman et al. 2006). We use 
the 3-digit level of the IPC classification (technology class) to categorize patents, and apply 
7 
 
fractional counting to apportion patents that belong to more than one technology class. Given 
the trade-off between precision and timeliness, we limit the citation window to a still 
informative three years. For the validation of the quality indices we use panel data for all 
domestic firms listed on the stock markets of mainland China covering the years 2001-2009. 
For details on the firm data see Boeing et al. (2016). 
 
3.2 Main quality index 
IndexF, with a mean value of 32.1%, shows that China’s patent quality is significantly 
below that of the comparison group, which consists mainly of high-income countries 
(Table 1). Between 2001 and 2009, the decline of indexF, from 44.9% to 30.4%, is a result of 
the decrease in the average number of citations obtained by Chinese PCT applications; 
whereas the citations received by the comparison group remain relatively stable. In global 
perspective, the USA leads with an average value of 123.3%, followed by Korea (93.5%), 
Germany (71.9%), Japan (59.6%), and China (32.1%). The respective comparison groups 
include all countries except the country of interest. Given that the probability of obtaining a 
foreign ISR citation is lower if a country has a larger share in worldwide PCT applications, 
the size of a country’s PCT stock negatively affects indexF. However, as China’s share of 
global PCT applications (2% in 2001, 5% in 2009) remained far below the US share (40% in 
2001, 29% in 2009), the exclusion of domestic citations penalizes China less than the USA. 
Additional results concerning individual PCT applicant countries can be found in the 
appendix.   
 
8 
 
Table 1. IndexF for major PCT applicant countries 
 China United States Korea Germany Japan 
Mean of indexF 
2001 44.9 115.9 74.4 67.1 73.1 
2002 34.2 122.7 87.0 72.0 70.1 
2003 38.8 113.5 73.9 75.6 66.9 
2004 34.4 105.4 89.3 75.9 65.1 
2005 41.0 114.4 104.8 72.2 61.1 
2006 30.7 116.1 108.5 68.5 57.7 
2007 29.0 127.0 105.4 66.5 57.0 
2008 29.8 134.9 95.7 73.3 53.4 
2009 30.4 158.8 80.4 76.1 49.1 
Total 32.1 123.3 93.5 71.9 59.6 
Count of PCT applications 2001-2009 
Total 34,738 360,653 44,314 138,212 201,633 
Note: Annual mean values for indexF displayed as percentages for the five largest PCT applicant countries 
between 2001 and 2009. The respective comparison group includes the PCT population from all other countries. 
 
Even though the core elements of PCT applications are published in English – i.e. 
abstract, title, search report, and text of drawings – other elements may only be available in 
the applicant’s language. Potential language barriers deter patent examiners from identifying 
prior art from a specific country, and must therefore be accounted for. Comparing PCT 
applications of Chinese origin published in Chinese or English, we calculate a negative 
language bias for citation counts and obtain a correction factor of 1.11 for indexF. After 
correcting for the language bias, China’s indexF increases modestly from 32.1% to 35.6%. 
The appendix provides details about the role of language in the search for prior art and in the 
calculation of the correction factor.1  
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
 
 
 
 
1 The intuition behind the correction factor is as follows. From 2001 to 2009, there is no English publication or 
equivalent document in English available for 56% of PCT applications of Chinese origin. Only these 
applications require an adjustment. We quantify the language bias by calculating the share of non-self-citations 
from outside of China in all non-self-citations made before and after a document in English is available. As this 
share increases by 38 percentage points, from 31% to 69%, we arrive at an adjustment factor of 1.38. We apply 
this factor in full for PCTs that do not obtain an English equivalent during the full 3-year citation window and 
weigh the factor for PCTs that obtain an English equivalent within three years. Taking the relative importance of 
the different cases into account, we arrive at a final correction factor of 1.11. 
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3.3 National technological capacity 
We measure national technological capacity by quality-adjusted patent counts, i.e. by 
multiplying PCT counts with the year- and country-specific mean value of indexF. Figure 1 
shows the development of PCT applications with and without quality adjustment for the five 
largest applicant countries. Where exclusively patent counts are considered, the USA takes 
the leading position. This lead is increased when moving to the quality-adjusted PCT 
applications – highlighting the technological influence of the USA. Due to the 3-year citation 
window, we can only calculate the index up to 2009. However, extrapolating the quality-
adjusted count by multiplying the patent counts with the average value of the index for the 
time period 2001-2009, enables us to obtain the quality-adjusted count up to 2013. Without 
quality adjustment, China takes the third position, thereby overtaking Germany and Korea. If 
quality adjustment is applied, China remains in the fifth position.  
 
Figure 1. Annual PCT applications and national technological capacities 
 
Note: The left figure shows the number of annual PCT applications for the five largest applicant countries 
between 2001 and 2013, as reported in WIPO (2014a). In the right figure quality adjusted PCT applications are 
shown. Numbers for 2010 onwards rely on an extrapolation. 
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3.4 Alternative quality indices 
Having reported our main results, we now expand the discussion to the two variations 
of the ISR index. In contrast to indexF  (32.1%), indexFD (61.6%) and indexFDS (90.0%) indicate 
a Chinese quality level closer to that of the comparison group. In recent years, indexFD 
converges towards the comparison group while indexFDS surpasses it. The increasing 
discrepancy among indices reveals that in global comparison China relies disproportionally on 
domestically-developed technologies. 
 
Table 2. Quality of Chinese PCT applications 
 IndexF IndexFD IndexFDS PCT applications 
2001 44.9 37.3 36.3 793 
2002 34.2 32.0 30.1 1,060 
2003 38.8 35.3 31.8 1,368 
2004 34.4 27.7 32.0 1,948 
2005 41.0 38.8 44.5 3,321 
2006 30.7 42.4 51.5 4,649 
2007 29.0 55.3 72.6 5,799 
2008 29.8 76.3 112.0 6,159 
2009 30.4 89.1 151.8 9,641 
Total 32.1 61.6 90.0 34,738 
Note: Annual mean values for indexF, indexFD, and indexFDS displayed as percentages for the years between 2001 
and 2009. Index values are calculated for all Chinese PCT applications in comparison to all non-Chinese PCT 
applications. 
 
We briefly summarize results for patent quality according to the six technology areas 
electrical engineering, chemistry, mechanical engineering, consumer goods and construction, 
instruments, and process engineering. Patents in the field of electrical engineering, which 
constitute with 57% the majority of China’s PCT applications, exhibit the largest difference 
between indexF (27.5%) and indexFDS (97.6%). The dominance of electrical engineering is 
related to the activities of ZTE and Huawei, two globally operating ICT firms that together 
file one third of Chinese PCT applications. Both firms receive fewer foreign citations than the 
average Chinese application but, as is consistent with their large size, exhibit considerably 
more self-citations. Applications in chemistry, the second largest category with 13%, display 
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the smallest difference between indexF (38.4%) and indexFDS (49.3%). In contrast to the 
complex technology electrical engineering, chemistry is a discrete technology and is not 
dominated by a few firms. The differences in the remaining technology areas are in between 
those reported for electrical engineering and chemistry.  
 
3.5 Validation of indices 
The expansion of Chinese PCT applications may contribute to higher levels and 
annual increases of indexFD and indexFDS. This is the case regardless of actual patent quality, as 
it simply means that there are more citing applications. With China as the focal country, the 
effect on domestic citations requires further investigation, whereas the effect on citations 
received by the international comparison group is negligible – only 3.8% of foreign non-self-
citations originate from China. As China’s patent expansion has been driven by economic 
policy, in particular by patent subsidies (Lei et al. n.d., Li 2012, Dang and Motohashi 2015), 
we test whether citations resulting from Chinese applications are a reliable indicator of patent 
quality. 
We calculate the ISR indices for patent portfolios of all domestic firms listed in 
mainland China and regress the indices on relevant firm characteristics. Table 3 provides 
descriptive statistics for firms with at least one PCT application and Table 4 shows the 
regression results. For the analysis we use a Tobit model because the dependent variable is 
truncated at zero. Given that R&D is a leading input factor for patent quality, we expect that 
citations increase in the R&D stock of firms. While the significant relationship of indexF with 
R&D confirms that foreign PCT applications more often cite patents from Chinese firms with 
more extensive R&D, this relationship cannot be confirmed for indexFD and indexFDS. The 
reliability  of  Chinese  citations   as  a   measure   of  quality  must   therefore  be  questioned.  
 
12 
 
Table 3: Descriptive statistics 
Variable Mean Median Std. dev. Min Max Obs. 
IndexF 43.3 0 135.2 0 1,350.4 451 
IndexFD 76.4 0 154.2 0 923.7 451 
IndexFDS 87.5 0 139.4 0 890.4 451 
R&D stock (million RMB) 487.89 30.45 2,184 0 25,001 451 
PCT intensity 3.505 0.825 8.673 0.005 100 451 
Domestic patent intensity 55.179 8.589 216.640 0 2,920 451 
Employees 20,237 3,126 68,680 10 539,168 451 
Firm age 11.49 11 5.057 1 29 451 
Private ownership 0.417 0  0 1 451 
Provincial GDP/capita (RMB) 30.996 29,447 15,786 5,905 66,006 451 
Note: Statistics based on firms with at least one PCT application. ISR indices are calculated as averages of 
annual patent applications. 
 
 
 
Table 4: Results of Tobit estimations 
 (1) (2) (3) 
 IndexF IndexFD IndexFDS 
ln(R&D stock) 
 
0.175*** 
(0.063) 
0.038 
(0.034) 
-0.004 
(0.026) 
PCT intensity 
 
0.232*** 
(0.049) 
0.082** 
(0.042) 
0.051* 
(0.028) 
Domestic patent intensity 
 
-0.006** 
(0.003) 
-0.001 
(0.002) 
-0.001 
(0.001) 
ln(employees) 
 
0.249 
(0.230) 
0.199 
(0.145) 
0.209** 
(0.094) 
ln(age) 
 
-0.821 
(0.672) 
-0.139 
(0.433) 
-0.025 
(0.287) 
Private ownership 
 
0.803 
(0.670) 
-0.111 
(0.441) 
-0.052 
(0.291) 
ln(provincial GDP/capita) 
 
-0.722 
(0.640) 
-0.253 
(0.444) 
-0.424 
(0.338) 
Industry controls Yes Yes Yes 
Year controls Yes Yes Yes 
Observations (firms) 451 (228) 451 (228) 451 (228) 
Log pseudo likelihood -346.73 -545.05 -607.70 
Note: Analysis at firm-year level. The dependent variable is the average quality index of a firm’s annual patent 
applications. Tobit estimation with standard errors clustered at the firm-level. Average marginal effects are 
reported in square brackets. Reference category for year is 2001. ***, **, * indicate statistical significance at the 
1%, 5%, and 10% levels. 
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Furthermore, only indexF significantly decreases in 2009 when national PCT subsidies were 
introduced (Chinese Ministry of Finance 2009). This decrease suggests that subsidies have a 
negative effect on patent quality. In a robustness check based on the Heckman two-step 
approach, which takes the selection into having at least one PCT application into account, we 
confirm the results of the Tobit models based on 12,575 observations for 1,743 listed firms. 
We conclude that indexF is the most appropriate ISR index for measuring patent quality in the 
Chinese context. As economic policy has no direct influence on the index, changes in indexF 
reflect true variation in patent quality. Additional robustness exercises can be found in the 
appendix. 
 
4. Discussion 
We derive two implications from our analysis. First, the expansion of Chinese PCT 
applications has occurred at the cost of patent quality. Although China has undergone an 
unforeseen increase in patent applications (Porter and Stern 1999), its technological capacity 
has increased less than would be expected if one considers only the number of patents applied 
for. Quality-adjusted patent counts should therefore be used by policymakers and R&D 
managers when comparing national technological capacities. Second, we empirically confirm 
that measures stop serving as reliable measures if they become the target of economic policy 
(Goodhart 1975, Lucas 1976). In response to subsidies, for example, Chinese applicants 
divide inventions into several applications in order to increase subsidy income (Lei et al. n.d.). 
Accordingly, Chinese patent applications and citations thereof are questionable measures of 
innovation levels and quality.  
Having achieved a vast expansion in the number of applications made both 
domestically and abroad, the Chinese government must now ensure that China’s rising R&D 
investments, which are forecasted to overtake those of the USA in 2019 (OECD 2014), yield 
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higher patent quality and thereby contribute to technological capacity and economic growth. 
From a global perspective, our analysis shows that Eastern technological capacity is not yet 
dominating, but the West’s leading position largely depends on the performance of the USA. 
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Appendix 
Measuring patent quality and national technological capacity  
in cross-country comparison 
Philipp Boeing and Elisabeth Mueller 
 
A. Supplementary Background Information 
A. 1. The PCT application process 
Under the PCT system, applications are filed with a competent Receiving Office (RO). 
During the 30 months following the priority date, PCT applications remain in the international 
phase. The designated International Search Authority (ISA) publishes the International Search 
Report (ISR) 18 months after the priority date. References to prior art are contained in the 
ISR, and the strict PCT guidelines for these references are identical for all ISAs. After 30 
months have elapsed, the application enters the national phase in which national patent offices 
perform additional search and examination before making the grant decision. Citations in the 
national phase may differ from ISR citations as the former follow national guidelines. In order 
to restrict the citations to one institutional setting, we do not consider citations generated 
during the national phase for our quality index.  
The home country of the applicant determines which ROs and ISAs may be 
approached for the processing of the application. The PCT procedure stipulates that Chinese 
applicants must file PCT applications with the Chinese Patent Office (SIPO) as the Receiving 
Office (RO). SIPO is also the only competent office to act as ISA and write an International 
Preliminary Examination Report (IPER).  
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A. 2. Determination of prior art for PCT applications 
In the PCT system, applicants are encouraged to provide references to prior art. The 
description of the application should “indicate the background art which, as far as known to 
the applicant, can be regarded as useful for the understanding, searching and examination of 
the invention, and, preferably, cite the documents reflecting such art” (Rule 5 of WIPO 
2014c). This PCT rule strikes a balance between the regulations of the US Patent and 
Trademark Office (USPTO) and the European Patent Office (EPO). Whereas the USPTO 
requires applicants to provide references to all relevant prior art that they are aware of, the 
EPO requires only that examiners, and not applicants, carry out this task (Michel and Bettels 
2001). In the PCT system it is ultimately the examiner who, according to strict guidelines, 
determines which references are included in the ISR. Such selected references are an 
appropriate measure of patent quality as they constitute an evaluation by a third party, namely 
by the examiner, of the technical and legal relationships between patents. Prior work has 
indicated that examiner citations show a much stronger correlation with patent value than 
applicant citations (Hegde and Sampat 2009). 
The search for prior art for PCT applications follows internationally identical 
guidelines. Citations are therefore internationally comparable and are not influenced by the 
nationality of the ISA conducting the search. The search guidelines explain in detail how 
citations are to be selected by the examiners (WIPO 2014b, §15.63-15.67). Examiners are 
encouraged, for example, to cite only the most relevant documents and, in the case that 
several members of one patent family are available, to cite documents in the language of the 
application (WIPO 2014b, §15.64). As we aggregate citations at the family level, our quality 
index is not influenced by which family member is ultimately cited. The international 
comparability of the index is further upheld by the fact that the search for prior art is highly 
concentrated among a few ISAs. According to WIPO (WIPO 2014a, p. 69), the top five ISAs 
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were responsible for more than 90% of ISRs in 2013 (EPO 37.7%, Japanese Patent Office 
(JPO) 20.7%, Korean Patent Office (KPO) 14.8%, SIPO 11.6%, USPTO 8.1%). 
 
A. 3. Potential language barriers in the selection of prior art 
Potential language barriers deter patent examiners from identifying prior art from a specific 
country and must therefore be accounted for in international comparisons of patent quality. 
Patent examiners typically begin their search for prior art with a keyword search in English, 
regardless of which searches, i.e. searches for the ISR or searches within national procedures, 
are conducted. Thorough prior art searches are, however, only possible if documents 
published in other languages can be found. The PCT system provides an English translation of 
the main parts of PCT applications; namely title, abstract, international search report, and any 
text relating to figures for all PCT applications not published in English (WIPO 2014c, Rule 
48.3 (c)). The abstract plays a key role in the search. According to Rule 8.3 (WIPO 2014c) 
“The abstract shall be so drafted that it can efficiently serve as a scanning tool for purposes of 
searching in the particular art, especially by assisting the scientist, engineer or researcher in 
formulating an opinion on whether there is a need for consulting the international application 
itself”. PCT applications, even if not originally published in English, are therefore easily 
identifiable as potentially relevant prior art.  
According to further guidelines of the PCT system, patent examiners conducting the 
international search must have access to the minimum documentation, which specifies the set 
of prior art that examiners must be able to search. PCT applications, irrespective of the 
publication language, belong to the minimum documentation and are therefore fully 
accessible during the search process. Patent applications belonging to the minimum 
documentation are typically included in the databases most commonly used for search by 
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examiners (e.g. Derwent World Patents Index (DWPI), Chemical Abstracts Service (CAS), 
and EPOQUE at the EPO).  
When it comes to deciding whether a document is ultimately to be included as prior 
art, patent examiners aim to consult the full application text. Examiners working at ISAs have 
access to a number of tools when dealing with prior art published in Chinese that has no 
English equivalent, i.e. if the patent family does not contain an application filed in another 
country in English. At the EPO, for example, as a first line of support, examiners are able to 
call on colleagues who are native Chinese speakers to help them determine the relevance of a 
document. If the document is deemed relevant, examiners may then request a human 
translation of the full text. Since 2008, machine translations of Chinese documents have 
served as an intermediate step prior to requesting a human translation. Indeed, since April 
2008, SIPO has provided the public with free machine translations of the full texts of its 
patents through its website (Kaemmer 2010). Since 2012, examiners at the EPO have been 
able to submit documents for machine translation from Chinese into English through their 
search system EPOQUE. This improvement has taken place after the end of our observation 
period. 
By conducting interviews with patent examiners of several patent offices, we have 
tried to identify possible biases against citing prior art originally published in Chinese. In 
making their decision as to whether prior art written in Chinese is relevant, examiners claim 
that they are not influenced by their familiarity with the country or applicant. Overall, 
examiners are eager to find the most appropriate prior art. It has been acknowledged by a 
subgroup of examiners, however, that under time pressure, prior art in Chinese may be less 
likely to be included in the search report. This is particularly the case if alternative documents 
in English are readily available, and if these provide sufficient ground to negate a claim or to 
reject an application in its entirety.  
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As the majority of patent examiners working at non-Chinese ISAs have no command 
of Chinese, we address the insights from our interviews by quantifying the related language 
bias. From 2001 to 2009, the majority (91%) of PCT applications made by Chinese applicants 
were published in Chinese with the remainder (9%) published in English. However, at the 
time of publication, there is no equivalent document in English for only 56% of PCT 
applications of Chinese origin.  
We quantify the language bias by calculating the share of non-self-citations from 
outside of China in all non-self-citations made before and after an English equivalent is 
available.2 As this share increases by 38 percentage points, from 31% to 69%, we arrive at an 
adjustment factor of 1.38 for the set of PCTs that do not obtain an English equivalent during 
the full 3-year citation window (1,095 days). For PCTs that obtain an English equivalent 
within three years, we weight the adjustment factor by 664/1,095 to account for the average 
time period after which an English equivalent is obtained, namely 664 days after publication. 
PCTs with English equivalents at publication are not subject to bias and require no correction. 
Taking the relative importance of the three groups into account, our weighted correction 
factor for ISR indexF is 1.11.3 As the increase of foreign citations is partially a result of the 
time required for the geographic diffusion of knowledge (Jaffe et al. 1993, Peri 2005), the 
calculated correction factor represents an upper limit for the pure language bias. 
 
 
 
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
 
 
 
 
2 Self-citations from outside China may occur if an international subsidiary of a Chinese firm cites inventions of 
its mother company. 
3 The size of the language barrier is substantial for affected applications but the overall effect is smaller as not all 
applications are affected to the full extend. A more detailed analysis of the role of language barriers for the 
content of search reports requires future research. 
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A. 4. Impact of China’s patent policies 
China’s patent expansion follows quantitative targets set by governmental economic policies.4 
In support of these targets, numerous provincial and sub-provincial subsidy programs 
incentivize patenting, often by supporting domestic as well as international applications. In 
2009, the central government also introduced subsidies for PCT patents (Chinese Ministry of 
Finance 2009).5 Research not only indicates a positive influence of patent subsidies on patent 
expansion (Li 2012), but also shows that in response to subsidies, applicants divide inventions 
into several applications in order to increase subsidy income (Lei et al. n.d.). Interestingly, 
these studies do not find a decrease in the grant rate. Consequently, it seems that China’s 
economic policy not only increases the number of patent applications made, but also lowers 
examination standards, therefore making grant rates an unreliable measure of patent quality.6  
SIPO itself voiced its dissatisfaction in regard to this development. It has recently 
published two documents that criticize the abundance of provincial and city-level subsidies 
for patent applications and the low examination standards at provincial and city-level patent 
offices (State Intellectual Property Office 2013, 2014). SIPO suggests that increases in the 
number of applications are detrimental to average patent quality and demands stricter 
monitoring of examination standards. Furthermore, SIPO proposes that application-based 
subsidy schemes are replaced by schemes based on actual grants, thereby reducing excessive 
applications and favoring patent quality over quantity.  
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
 
 
 
 
4 Recent cornerstones of China’s innovation policy include the “Medium- to Long-term Plan for Science and 
Technology Development (2006-2020),” the “National Patent Development Strategy (2011-2020),” and the 
current “Five-Year Plan for Science and Technology Development.” 
5 Applications in up to five countries (regions) are subsidized with up to 100,000 RMB each (ca. 14,600 USD, 
exchange rate of 31.12.2009). Exceptions are possible for projects involving significant innovation. Subsidies 
should mainly cover examination fees, patent agent service fees, and renewal fees. Applications are only 
subsidized once. 
6 The effect of China’s economic policy on examination standards may be direct, if provincial policy makers 
encourage constant grant rates, or indirect, if examiners are confronted with an increasing number of applications 
– leading to considerably less time for examination, which negatively affects the probability of discovering prior 
art. 
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B. External validation of ISR indices – Additional analysis for listed firms 
B. 1. Data 
In order to externally validate our ISR indices we calculate them for the applications of 
Chinese firms and relate them to firm characteristics. We observe the population of domestic 
Chinese firms listed at the two stock exchanges in Shanghai and Shenzhen between 2001 and 
2009. Due to governmental stock issuance quotas, the listed firms are adequately 
representative of the Chinese economy’s industrial composition, with large manufacturing 
firms strongly represented in more developed Coastal regions (Pistor and Xu 2005). It should 
be noted that the China Securities Regulatory Commission only allows listings of “domestic” 
Chinese firms, i.e. the percentage of total shares held by foreign parties can not exceed 20%. 
This implies that foreign subsidiaries operating in China are excluded from firm-level 
analysis.  
Our panel data of standard firm characteristics is drawn from the following sources. 
R&D expenditures for the years from 2001 to 2005 are collected manually from annual 
reports (CNINFO). For the years from 2006 to 2009 they are obtained from the Chinese 
database WIND. Patent data is obtained from the April 2013 version of the EPO Worldwide 
Patent Statistical Database (PATSTAT) and matched to firm data (Boeing et al. 2016). The 
number of employees is obtained from Datastream and the date of firm establishment and 
industry affiliation from WIND. Information on state ownership is obtained from RESSET. 
Provincial GDP per capita is obtained from the Chinese National Bureau of Statistics. 
 
B. 2. Regression analysis 
B. 2.1 Dependent variables 
We use regression analysis for the external validation of the ISR indices. The dependent 
variables include indexF, indexFD, indexFDS and, in addition, two indices that exclusively 
24 
 
consider domestic or self-citations. As a first step, we compare the patent quality in the 
sample of listed firms (Table B1) with the quality of all Chinese PCT applications (Table 1). 
Whilst the values for indexF and indexFD are very similar, we see a larger value for indexFDS. 
This is to be expected as listed firms are larger than average firms. We then move from the 
patent level to the firm-year level and calculate the average index value over all PCT 
applications filed by a firm in a given year for each observation. The statistics for our main 
indices are provided in Table B2. IndexF has an average value of 43.3%, indexFD of 76.4%, 
and indexFDS of 87.5%. The averages in Table B2 differ from those in Table B1 due to 
weighting. At the patent level, each patent has the same weighting, whereas at firm-year level 
each firm observation has the same weighting regardless of the size of the patent stock.  
 
B. 2.2 Firm characteristics and standard controls 
We briefly discuss the descriptive statistics of the firm characteristics for the 228 firms with 
PCT applications for which we have 451 observations (Table B2). Employing the perpetual 
investment method, we calculate deflated R&D stocks based on an assumed annual growth 
rate of R&D of 20% and a standard annual depreciation rate of 15%. The resulting median 
R&D stock has a value of 30.45 million RMB. PCT and domestic patent intensity are 
calculated as the respective patent stocks of the firm depreciated by an annual rate of 15% and 
scaled by ‘000 employees. We find that intensity is much smaller for PCT than for domestic 
applications. Firms with PCT applications are relatively large; the median number of 
employees is 3,126 and the firms themselves tend to be relatively young, with a median age of 
11 years. We broadly differentiate between firms with and without any government ownership 
and find, that according to this differentiation, 41.7% of observations are private firms. To 
allow for differences in China’s economic development, we control for deflated GDP per 
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capita at the provincial level. In addition, we account for macro-economic shocks and 
industry-specific effects by including year- and industry-dummies, respectively. 
 
B. 2.3 Results 
In Table B3 we estimate a Tobit model with standard errors clustered at the firm-level. For the 
analysis we use a Tobit model because the dependent variable is truncated at zero. Average 
marginal effects are listed to the right of coefficients. In Model (1) we regress indexF on our 
set of firm characteristics and standard controls. We find positive and highly significant 
effects (p<0.01) for the R&D stock and PCT intensity, but a significantly negative effect 
(p<0.05) for domestic patent intensity. A 1% increase in the R&D stock corresponds to an 
increase in the quality index by 3.6 percentage points. Adding one unit to the PCT intensity 
increases indexF by 4.7 percentage points, whereas adding one unit to the domestic patent 
intensity decreases indexF by 0.1 percentage points.  
These results indicate a positive and economically important relationship between 
R&D, which is the most important input factor for innovation, and patent quality. The 
opposite signs for PCT intensity and domestic patent intensity suggest that international and 
domestic patenting strategies are differently related to patent quality. Further, our year 
dummies show a negative time trend, which becomes more pronounced in recent years and 
turns weakly significant (p<0.1) with the introduction of national PCT subsidies in 2009. In 
line with the sizable expansion in PCT applications between 2001 and 2009, it seems 
plausible that the increase in quantity coincides with a decrease in quality.  
In Model (2), we change the dependent variable to indexFD. With the exception of the 
PCT intensity, which remains positive and significant (p<0.05), all remaining regressors 
become insignificant. In Model (3) we change the dependent variable to indexFDS. The PCT 
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intensity remains positive but is only weakly significant (p<0.1). The expected positive 
correlation between firm size and self-citations is also confirmed (p<0.05).  
Given that the expected correlation between R&D stock and patent quality is 
confirmed only for indexF, we aim to estimate the effect of the R&D stock on two indices that 
exclusively consider either domestic or self-citations in Model (4) and (5). These models fail 
to show a significant relation between R&D stock and patent quality. Whilst we fail to 
identify any significant effects in Model (4), Model (5) reveals a positive and highly 
significant (p<0.01) correlation of ISR self-citations with PCT intensity and firm size 
(measured by the number of employees). In addition, the domestic patent intensity has a 
negative and highly significant (p<0.01) effect. Model (5) resembles the findings of Model (3) 
with higher significance levels and larger marginal effects. In addition, Model (5) suggests 
that the inventive activity of firms generates significantly more self-citations in the years 2008 
(p<0.05) and 2009 (p<0.01). 
To summarize, these findings suggest that indexF is the preferable measure of patent 
quality in China because domestic citations and self-citations are not correlated with R&D 
stocks. We therefore perform additional robustness tests for indexF, which are reported in 
Table B4. For ease of reference we repeat the standard Tobit results as Model (1). In Model 
(2) we conduct a random effects Tobit estimation with the Chamberlain-Mundlak device and 
confirm a positive and highly significant correlation between indexF and the R&D stock. This 
random-effects model achieves consistent results even if the time-invariant error term is not 
independent from our time-variant regressors. The model includes the average value of time-
variant regressors as additional controls in the regression specification. The magnitude of the 
marginal effect is comparable to the magnitude estimated in our standard Model (1).  
In Models (3a) and (3b) we not only consider firms with PCT applications but include 
all listed firms. We estimate the selection and outcome equation of a Heckman two-step 
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selection model using the number of employees as an exclusion restriction. Our results show 
that large firms are more likely to file PCTs. Indeed, the number of employees has a non-
trivial and positive effect at the 1% significance level on selection. As expected, ߩ confirms a 
positive correlation of residuals in the selection and outcome equation. Nonetheless, the 
coefficient of ߣ , which is the covariance of the error terms of both equations, is not 
significant. This finding shows that additional unobservables are unlikely to induce significant 
selection bias. We find that the R&D stock has a positive and highly significant effect 
(p<0.01) on the probability of filing at least one PCT application (Model 3a) and a positive 
and highly significant effect (p<0.01) on receiving foreign ISR citations (Model 3b). The 
marginal effect of the R&D stock in Model (3b) is smaller than in Model (1), as the first stage 
in Model (3a) already partly captures its influence on PCT applications. 
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Table B1: Quality of PCT applications of Chinese listed firms 
 IndexF IndexFD IndexFDS Obs. 
2001 60.3 85.3 94.2 53 
2002 56.6 56.5 68.3 102 
2003 42.3 52.7 48.2 159 
2004 81.7 78.1 68.0 195 
2005 56.0 69.9 56.0 347 
2006 55.7 61.0 65.2 429 
2007 46.7 74.1 102.4 710 
2008 23.1 62.4 144.7 871 
2009 18.7 61.2 152.4 2,318 
Total 33.1 64.3 121.9 5,184 
Note: Mean values of variables displayed as percentages. 
 
 
 
 
 
 
 
Table B2: Descriptive statistics 
Variable Mean Median Std. dev. Min Max Obs. 
IndexF 43.3 0 135.2 0 1,350.4 451 
IndexFD 76.4 0 154.2 0 923.7 451 
IndexFDS 87.5 0 139.4 0 890.4 451 
R&D stock (million RMB) 487.89 30.45 2,184 0 25,001 451 
PCT intensity 3.505 0.825 8.673 0.005 100 451 
Domestic patent intensity 55.179 8.589 216.640 0 2,920 451 
Employees 20,237 3,126 68,680 10 539,168 451 
Firm age 11.49 11 5.057 1 29 451 
Private ownership 0.417 0  0 1 451 
Provincial GDP/capita (RMB) 30.996 29,447 15,786 5,905 66,006 451 
Note: Statistics based on firms with at least one PCT application. ISR indices are calculated as averages of 
annual patent applications. 
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Table B3: Results of Tobit estimations 
(1) (2) (3) (4) (5)
 IndexF IndexFD IndexFDS Index domestic cit. Index self cit. 
ln(R&D stock) 
 
0.175*** 
(0.063)
[0.036] 0.038 
(0.034)
[0.011] -0.004 
(0.026) 
[-0.001] -0.084 
(0.114)
[-0.019] -0.114 
(0.078)
[-0.027] 
PCT intensity 
 
0.232*** 
(0.049)
[0.047] 0.082** 
(0.042)
[0.023] 0.051* 
(0.028) 
[0.018] 0.184 
(0.134)
[0.041] 0.257*** 
(0.067)
[0.062] 
Domestic patent intensity 
 
-0.006** 
(0.003)
[-0.001] -0.001 
(0.002)
[-0.0004] -0.001 
(0.001) 
[-0.0002] -0.002 
(0.005)
[-0.001] -0.007*** 
(0.003)
[-0.002] 
ln(employees) 
 
0.249 
(0.230)
[0.051] 0.199 
(0.145)
[0.056] 0.209** 
(0.094) 
[0.072] 0.834 
(0.524)
[0.186] 1.057*** 
(0.348)
[0.255] 
ln(age) 
 
-0.821 
(0.672)
[-0.168] -0.139 
(0.433)
[-0.039] -0.025 
(0.287) 
[-0.009] 0.485 
(1.612)
[0.108] 0.218 
(0.894)
[0.053] 
Private ownership 
 
0.803 
(0.670)
[0.164] -0.111 
(0.441)
[-0.031] -0.052 
(0.291) 
[-0.018] -0.877 
(1.444)
[-0.196] 0.104 
(0.998)
[0.025] 
2002 
 
-1.591 
(2.311)
[-0.428] -1.210 
(1.585)
[-0.361] -0.806 
(1.046) 
[-0.240] -1.291 
(5.053)
[-0.257] 0.374 
(2.155)
[0.063] 
2003 
 
-2.580 
(2.393)
[-0.651] -2.106 
(1.494)
[-0.583] -1.359 
(0,999) 
[-0.377] -3.769 
(4.867)
[-0.700] -1.622 
(2.962)
[-0.249] 
2004 
 
-0.571 
(2.213)
[-0.164] -1.406 
(1.516)
[-0.413] -0.372 
(0.946) 
[-0.117] -7.655 
(5.738)
[-1.280] 1.607 
(2.808)
[0.286] 
2005 
 
-2.126 
(2.122)
[-0.552] -2.137 
(1.406)
[-0.590] -1.250 
(0.928) 
[-0.352] -6.123 
(4.893)
[-1.066] -0.708 
(2.616)
[-0.113] 
2006 
 
-2.251 
(2.253)
[-0.580] -1.373 
(1.467)
[-0.404] -0.373 
(0.960) 
[-0.117] -1.556 
(4.807)
[-0.308] 2.931 
(2.719)
[0.555] 
2007 
 
-3.253 
(2.455)
[-0.786] -1.664 
(1.527)
[-0.478] -0.549 
(1.008) 
[-0.169] 0.012 
(4.929)
[0.003] 1.750 
(2.767)
[0.313] 
2008 
 
-3.313 
(2.399)
[-0.797] 0.080 
(1.464)
[0.027] 0.722 
(0.960) 
[0.261] 6.238 
(4.874)
[1.569] 5.336**  
(2.491)
[1.139] 
2009 
 
-4.146* 
(2.278)
[-0.948] -0.480 
(1.461)
[-0.153] 1.535 
(0.957) 
[0.617] 4.974 
(4.968)
[1.201] 9.017*** 
(2.696)
[2.332] 
ln(provincial GDP/capita) 
 
-0.722 
(0.640)
[-0.147] -0.253 
(0.444)
[-0.071] -0.424 
(0.338) 
[-0.147] -0.262 
(1.425)
[-0.058] -1.605 
(1.127)
[-0.388] 
Industry controls Yes  Yes  Yes  Yes  Yes  
Observations (firms) 451 (228)  451 (228)  451 (228)  451 (228)  451 (228)  
Log pseudo likelihood -346.73  -545.05  -607.70  -485.14  -488.74  
Note: Analysis at firm-year level. The dependent variable is the average quality index of a firm’s annual patent applications. Tobit estimation with standard errors clustered at 
the firm-level. Average marginal effects are reported in square brackets. Reference category for year is 2001. ***, **, * indicate statistical significance at the 1%, 5%, and 10% 
levels. 
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Table B4: Results of alternative estimations 
 (1) (2) (3a) (3b)
 Tobit RE Tobit Heckman (selection equation)  Heckman (outcome equation)  
 IndexF IndexF PCT application (0/1) IndexF 
ln(R&D stock) 
 
0.175*** 
(0.063) 
[0.036] 
 
0. 190*** 
(0.074) 
[0.038] 
 
0.027*** 
(0.004) 
[0.002] 
 
0.029*** 
(0.011) 
[0.012] 
 
PCT intensity 
 
0.232*** 
(0.049) 
[0.047] 
 
0.229*** 
(0.081) 
[0.046] 
 
0.130*** 
(0.009) 
[0.008] 
 
0.028** 
(0.014) 
[0.011] 
 
Domestic patent intensity 
 
-0.006** 
(0.003) 
[-0.001] 
 
-0.008* 
(0.004) 
[-0.002] 
 
0.0002 
(0.0004) 
[0.00001] 
 
-0.001 
(0.0004) 
[-0.0003] 
 
ln(employees) 
 
0.249 
(0.230) 
[0.051] 
 
-0.425 
(0.613) 
[-0.084] 
 
0.310*** 
(0.021) 
[0.019] 
 -- 
-- 
 
ln(age) 
 
-0.821 
(0.672) 
[-0.168] 
 
-4.103* 
(2.292) 
[-0.816] 
 
-0.041 
(0.055) 
[-0.002] 
 
-0.180 
(0.141) 
[-0.073] 
 
Private ownership 
 
0.803 
(0.670) 
[0.164] 
 
0.603 
(1.155) 
[0.120] 
 
0.186*** 
(0.054) 
[0.011] 
 
0.117 
(0.136) 
[0.048] 
 
ln(provincial GDP/capita) 
 
-0.722 
(0.640) 
[-0.147] 
 
0.448 
(3.948) 
[0.089] 
 
0.350*** 
(0.045) 
[0.021] 
 
-0.113 
(0.140) 
[-0.046] 
 
Lambda 
       
0.082 
(0.180)  
Year controls Yes  Yes  Yes  Yes  
Industry controls Yes  Yes  Yes  Yes  
Rho     0.063 
Sigma     1.315 
Observations (firms) 451 (228)  451 (228)  12,575 (1,743) 
Log pseudo likelihood -346.73  -342.31  -2202.77 
Note: Analysis at firm-year level. The dependent variable is the average indexF of a firm’s annual patent applications (models 1, 2 and 4). The dependent variable of the first 
stage of the Heckman two-step selection model is a dummy indicating whether the firm has at least one PCT application (model 3). The RE Tobit model includes the 
Chamberlain-Mundlak device. Average marginal effects are reported in square brackets. ***, **, * indicate statistical significance at the 1%, 5%, and 10% levels. 
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C) Additional analysis for PCT applications 
In Table C1 we report citation counts for Chinese and non-Chinese PCT applications. 
Between 2001 and 2009, the decline of indexF, from 44.9% to 30.4% (as reported in Table 2 
of the main paper), is a result of the decrease in the average number of citations obtained by 
Chinese PCT applications in comparison to the relatively stable number obtained by the 
comparison group. Similarly, the increases of indexFD and indexFDS are due to increases in the 
average number of citations obtained by Chinese PCT applications, whereas the citations 
obtained by the non-Chinese comparison group are also stable over time.  
In order to consider the quality development of Chinese PCT applications from an 
international perspective, we calculate the average citation count according to the definition of 
indexF for the 19 largest applicant countries, including China. Table C2 provides the results 
when the technology composition of each country is weighted to reflect the distribution of 
China. This is done in order to present citation averages as they are used in the index 
calculation with China as the focal country. In our sample of 19 countries, China has the 
smallest average value of non-self-citations from foreign countries. Over the time period 
2001-2009, we observe a decrease in the average number of citations for only four countries 
(JP, CN, CH, IT), a relatively constant level in the case of nine countries (DE, FR, GB, CA, 
IL, ES, DK, BE, AT), and an increase for six countries (US, KR, NL, SE, FI, AU). 
To provide more general insight, we also present average citation counts according to 
the actual technology composition of each country. This corresponds to a country’s general 
development, independent from the comparison with China (Table C3). China again has the 
smallest average citation count. In this representation, however, the count is decreasing in ten 
countries (US, JP, DE, FR, GB, CN, CH, IT, IL, BE), constant in eight countries (KR, NL, 
SE, CA, FI, ES, DK, AT), and increasing in one country (AU). 
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Table C1: Citation counts for Chinese and non-Chinese PCT applications 
 Average citation counts 
 IndexF IndexFD IndexFDS 
 Chinese patents 
Non-
Chinese 
patents 
Chinese 
patents 
Non-
Chinese 
patents 
Chinese 
patents 
Non-
Chinese 
patents 
2001 0.131 0.276 0.165 0.424 0.217 0.587 
2002 0.079 0.249 0.108 0.371 0.144 0.528 
2003 0.085 0.241 0.112 0.348 0.148 0.499 
2004 0.074 0.224 0.088 0.317 0.143 0.448 
2005 0.091 0.230 0.126 0.323 0.199 0.442 
2006 0.074 0.258 0.154 0.364 0.262 0.495 
2007 0.075 0.292 0.235 0.414 0.407 0.545 
2008 0.077 0.302 0.311 0.431 0.627 0.580 
2009 0.076 0.292 0.325 0.426 0.781 0.576 
Total 0.079 0.276 0.234 0.396 0.473 0.536 
Note: Non-Chinese patents weighted according to the technology distribution of China. The values of “Chinese 
patents” and “non-Chinese patents” are the numerator and denominator values of the indices respectively. 
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Table C2: Average foreign ISR citations of national PCT applications (Chinese technology composition) 
 US JP DE FR KR GB NL CN CH SE IT CA FI AU IL ES DK AT BE 
2001 0.294 0.190 0.183 0.197 0.200 0.309 0.331 0.131 0.391 0.334 0.221 0.459 0.336 0.237 0.502 0.152 0.470 0.227 0.351 
2002 0.278 0.176 0.173 0.166 0.209 0.253 0.285 0.079 0.323 0.329 0.207 0.438 0.277 0.195 0.373 0.158 0.335 0.192 0.379 
2003 0.254 0.159 0.181 0.189 0.187 0.294 0.304 0.085 0.315 0.308 0.211 0.424 0.326 0.212 0.418 0.135 0.397 0.139 0.434 
2004 0.217 0.141 0.164 0.183 0.211 0.249 0.301 0.074 0.299 0.299 0.243 0.437 0.310 0.252 0.355 0.153 0.334 0.273 0.494 
2005 0.238 0.133 0.161 0.162 0.278 0.268 0.289 0.091 0.318 0.317 0.203 0.446 0.359 0.286 0.351 0.189 0.281 0.188 0.255 
2006 0.260 0.145 0.183 0.197 0.283 0.284 0.308 0.074 0.269 0.405 0.190 0.533 0.398 0.361 0.396 0.161 0.409 0.192 0.268 
2007 0.329 0.155 0.174 0.236 0.346 0.306 0.370 0.075 0.284 0.336 0.217 0.458 0.523 0.334 0.452 0.134 0.322 0.151 0.411 
2008 0.370 0.149 0.163 0.204 0.334 0.268 0.384 0.077 0.283 0.379 0.170 0.465 0.409 0.364 0.410 0.133 0.365 0.228 0.256 
2009 0.416 0.131 0.150 0.186 0.302 0.265 0.311 0.076 0.263 0.347 0.101 0.538 0.378 0.361 0.444 0.074 0.260 0.289 0.311 
Aver. cit.  0.331 0.145 0.165 0.196 0.295 0.276 0.330 0.079 0.285 0.351 0.172 0.487 0.399 0.330 0.417 0.128 0.328 0.221 0.325 
Note: Average annual citations with technology-composition of non-Chinese applications weighted according to 3-digit IPC composition of Chinese applications. The 
nationality of the PCT application is determined according to the country of the first applicant. 
 
Table C3: Average foreign ISR citations of national PCT applications (national technology composition) 
 US JP DE FR KR GB NL CN CH SE IT CA FI AU IL ES DK AT BE 
2001 0.307 0.186 0.169 0.202 0.200 0.308 0.297 0.131 0.434 0.383 0.194 0.461 0.423 0.217 0.514 0.154 0.497 0.221 0.406 
2002 0.279 0.161 0.161 0.170 0.196 0.262 0.264 0.079 0.355 0.319 0.179 0.445 0.365 0.177 0.419 0.151 0.404 0.192 0.362 
2003 0.243 0.144 0.152 0.175 0.163 0.277 0.276 0.085 0.361 0.305 0.182 0.386 0.369 0.174 0.412 0.124 0.419 0.166 0.429 
2004 0.215 0.125 0.140 0.165 0.181 0.239 0.258 0.074 0.394 0.279 0.191 0.380 0.330 0.246 0.403 0.143 0.440 0.244 0.345 
2005 0.219 0.118 0.137 0.151 0.208 0.229 0.264 0.091 0.342 0.281 0.166 0.388 0.349 0.227 0.419 0.139 0.350 0.146 0.369 
2006 0.237 0.119 0.136 0.162 0.221 0.247 0.287 0.074 0.345 0.347 0.168 0.435 0.369 0.286 0.389 0.176 0.422 0.181 0.376 
2007 0.256 0.121 0.130 0.178 0.251 0.241 0.301 0.075 0.360 0.306 0.161 0.395 0.443 0.277 0.430 0.132 0.428 0.170 0.366 
2008 0.273 0.117 0.145 0.158 0.233 0.242 0.315 0.077 0.315 0.343 0.152 0.415 0.402 0.278 0.411 0.162 0.413 0.201 0.302 
2009 0.275 0.101 0.136 0.143 0.184 0.209 0.299 0.076 0.312 0.300 0.127 0.415 0.318 0.288 0.410 0.116 0.356 0.172 0.307 
Aver. cit. 0.257 0.118 0.139 0.159 0.211 0.235 0.293 0.079 0.338 0.315 0.155 0.411 0.370 0.266 0.414 0.141 0.398 0.181 0.342 
Total PCT 360,691 201,681 138,23 52,167 44,343 42,699 35,369 34,738 27,186 26,139 21,214 19,122 15,658 13,960 11,329 9,639 9,252 7,420 7,401 
Note: Total PCT is the sum of the respective national PCT applications between 2001 and 2009. The nationality of the PCT application is determined according to the country 
of the first applicant.
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